Results 101 to 110 of about 44,122 (146)
Atrial Cardiomyopathy in Atrial Fibrillation: Mechanistic Pathways and Emerging Treatment Concepts. [PDF]
Karakasis P+6 more
europepmc +1 more source
Management Status of Myocarditis-Related Sudden Cardiac Death. [PDF]
Yan P, Yang S, Wang T.
europepmc +1 more source
[Anti-arrhythmia agents and sudden death].
openaire +1 more source
[Classification of anti-arrhythmia agents and their characteristics].
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Zeitschrift fur Kardiologie, 1993
Use of class-I antiarrhythmic agents (encainide, flecainide or moricizine) to suppress asymptomatic ventricular premature depolarizations does not decrease, but rather increases mortality from cardiac events after myocardial infarction. These patients should not be treated with antiarrhythmic drugs until improved survival is shown in a controlled ...
P, Honerjäger, G, Schmidt
openaire +1 more source
Use of class-I antiarrhythmic agents (encainide, flecainide or moricizine) to suppress asymptomatic ventricular premature depolarizations does not decrease, but rather increases mortality from cardiac events after myocardial infarction. These patients should not be treated with antiarrhythmic drugs until improved survival is shown in a controlled ...
P, Honerjäger, G, Schmidt
openaire +1 more source
Farmakologiia i toksikologiia, 1990
In experiments on 68 dogs with ventricular arrhythmia at the late stage of experimental myocardial infarction caused by the coronary artery branch occlusion it was shown that combinations of N-propylaimaline bromide (IA class of antiarrhythmic agents) with trimecaine (IB class) or anapriline (II class) or phynoptine (IV class) induce a significant ...
E I, Gendenshteĭn+3 more
openaire +1 more source
In experiments on 68 dogs with ventricular arrhythmia at the late stage of experimental myocardial infarction caused by the coronary artery branch occlusion it was shown that combinations of N-propylaimaline bromide (IA class of antiarrhythmic agents) with trimecaine (IB class) or anapriline (II class) or phynoptine (IV class) induce a significant ...
E I, Gendenshteĭn+3 more
openaire +1 more source
Advances in applications of anti-arrhythmia agents and safety evaluation
Pharmaceutical Care and Research, 2012Tao Chen+3 more
openaire +2 more sources
Proarrhythmische Effekte von Antiarrhythmika
DMW - Deutsche Medizinische Wochenschrift, 2008Stefan H. Hohnloser, Philip J. Podrid
openaire +3 more sources
[The cardiotoxic properties of anti-arrhythmia agents].
Eksperimental'naia i klinicheskaia farmakologiia, 1997Experiments were conducted on cats to study the cardiotoxic and arrhythmogenic properties of some antiarrhythmic agents in continuous intravenous infusion in doses multiple of the dose which causes an antiarrhythmic effect on an acontic model of arrhythmia in rats in 50% of cases.
A A, Spasov, N A, Gurova
openaire +1 more source